ロード中...
Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.
Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1982
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC497768/ https://ncbi.nlm.nih.gov/pubmed/7047575 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|